While radioligand therapies have gained significant traction in recent years, Invicro has been dedicated to nuclear medicine for over two decades, leading the forefront of the radiopharmaceutical boom.

Your preclinical and clinical trials need Invicro as your scientific and operational collaborator. Let’s meet to discuss your RLT programs:

We look forward to seeing you at #AAIC24 in Philadelphia from July 28 to August 1. Calyx / Invicro have been pioneers in Alzheimer’s research for over two decades, providing support in the majority of the most critical Alzheimer’s trials over the past ten years.

Stop by booth #921 and learn how we empower Alzheimer’s disease research with our extensive scientific and operational experience across preclinical, early-phase, and late-phase clinical studies. Schedule a meeting with our team: https://share.hsforms.com/1-o7LpdGDT8Gc9PtGTGq8vw2lkw4